Log in to save to my catalogue

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalo...

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4f7f418230ce468aace772cfd97ce8e6

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease

About this item

Full title

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease

Publisher

England: BioMed Central

Journal title

Alzheimer's research & therapy, 2022-02, Vol.14 (1), p.28-28, Article 28

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Cerebrospinal fluid (CSF) tau and beta-amyloid levels in chronic traumatic encephalopathy (CTE), a disease which can be clinically indistinguishable from Alzheimer's disease (AD), are largely unknown. We examined postmortem CSF analytes among participants with autopsy confirmed CTE and AD.
In this cross-sectional study 192 participants from the...

Alternative Titles

Full title

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4f7f418230ce468aace772cfd97ce8e6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4f7f418230ce468aace772cfd97ce8e6

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-022-00976-y

How to access this item